Emerging erythromycin and clindamycin resistance in group A streptococci: Efficacy of linezolid and tedizolid in experimental necrotizing infection-Reference-Cited by-同舟云学术

Emerging erythromycin and clindamycin resistance in group A streptococci: Efficacy of linezolid and tedizolid in experimental necrotizing infection

Published:2020-09 Issue: Volume:22 Page:601-607
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Bryant Amy E.,Bayer Clifford R.,Aldape Michael J.,McIndoo Eric,Stevens Dennis L.

Funder

Merck, Inc.

Department of Veterans Affairs, Biomedical Laboratory Research and Development Program, Career Scientist award

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference32 articles.

1. Practice guidelines for the diagnosis and management of skin and soft-tissue infections;Stevens;Clin Infect Dis,2005

2. Macrolide and clindamycin resistance in group A streptococci isolated from children with pharyngitis;DeMuri;Pediatr Infect Dis J,2017

3. The genetic features of drug resistance to group A streptococcus and macrolides antibiotics among pediatric patients in Beijing 2012 [in Chinese];Peng;Zhonghua Yu Fang Yi Xue Za Zhi,2013

4. Failure of clindamycin to eradicate infection with β-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections;Lewis;Antimicrob Agents Chemother,2014

5. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis;Stevens;J Infect Dis,1988

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report;Journal of Infection and Chemotherapy;2024-01

2. Comparison of Adjuvant Clindamycin vs Linezolid for Severe Invasive Group A Streptococcus Skin and Soft Tissue Infections;Open Forum Infectious Diseases;2023-11-24

3. Defining the Optimal Antibiotic Duration in Necrotizing Skin and Soft Tissue Infections: Clinical Experience from a Quaternary Referral Center;Surgical Infections;2023-10-01

4. HLA-II-Dependent Neuroimmune Changes in Group A Streptococcal Necrotizing Fasciitis;Pathogens;2023-07-31

5. Clindamycin resistance in Group A streptococcal infections: A single‐centre retrospective cohort study of 186 patients;Journal of the European Academy of Dermatology and Venereology;2023-03-08